Venrock Healthcare Capital Partners III L.P. 13D and 13G filings for Adverum Biotechnologies, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 8:26 pm Purchase |
2023-12-31 | 13G | Adverum Biotechnologies, Inc. ADVM |
Venrock Healthcare Capital Partners III L.P. | 1,556,421 7.500% |
966,472 (+163.82%) |
Filing |
| 2023-07-24 4:16 pm Purchase |
2023-07-14 | 13G | Adverum Biotechnologies, Inc. ADVM |
Venrock Healthcare Capital Partners III L.P. | 589,949 5.900% |
589,949 (New Position) |
Filing |